GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedMira Inc (OTCPK:MMIRF) » Definitions » Total Stockholders Equity

MedMira (MedMira) Total Stockholders Equity : $-11.98 Mil (As of Jan. 2024)


View and export this data going back to . Start your Free Trial

What is MedMira Total Stockholders Equity?

MedMira's Total Stockholders Equity for the quarter that ended in Jan. 2024 was $-11.98 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. MedMira's Book Value per Share for the quarter that ended in Jan. 2024 was $-0.02. The ratio of a company's debt over equity can be used to measure how leveraged this company is. MedMira's Debt-to-Equity for the quarter that ended in Jan. 2024 was -0.56.


MedMira Total Stockholders Equity Historical Data

The historical data trend for MedMira's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMira Total Stockholders Equity Chart

MedMira Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.31 -11.53 -12.55 -9.55 -11.38

MedMira Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.04 -10.43 -11.38 -11.53 -11.98

MedMira  (OTCPK:MMIRF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

MedMira's Book Value per Share for the quarter that ended in Jan. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

MedMira's Debt-to-Equity for the quarter that ended in Jan. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedMira Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of MedMira's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


MedMira (MedMira) Business Description

Traded in Other Exchanges
Address
155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3
MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma; H Pylori which detects antibodies in serum, plasma, and whole blood; syphilis which detects treponema pallidum antibodies in serum, plasma, and whole blood; among other products. The company generates revenue geographically from North America, Europe, Asia pacific. The majority of the revenue is generated from North America.

MedMira (MedMira) Headlines

From GuruFocus

MedMira Reports First Quarter Results FY2023

By ACCESSWIRE ACCESSWIRE 12-31-2022

MedMira receives CE mark for its VYRA(TM) CoV2Flu Antigen Test

By ACCESSWIRE ACCESSWIRE 01-11-2023

MedMira Reports Third Quarter Results FY2021

By GlobeNewswire GlobeNewswire 06-30-2021

MedMira Closes New Equity Investment for Future Growth

By GlobeNewswire GlobeNewswire 07-15-2021

MedMira Reports Third Quarter Results

By GlobeNewswire GlobeNewswire 06-30-2018

MedMira Introduces VYRA TriDemic

By ACCESSWIRE ACCESSWIRE 12-30-2022

Progress Update on Securities

By ACCESSWIRE 08-31-2023

MedMira Reports Third Quarter Results FY2022

By GlobeNewswire GlobeNewswire 06-30-2022